BioCentury
ARTICLE | Company News

Sysmex Corp., Merck KGaA deal

June 9, 2014 7:00 AM UTC

Merck exclusively partnered with Sysmex's Sysmex Inostics GmbH subsidiary to develop and commercialize a blood-based Ras biomarker test worldwide for patients with metastatic colorectal cancer (mCRC)...